Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
39.58 USD | -0.19% | +0.30% | +37.76% |
May. 09 | Wedbush Raises Price Target on Revolution Medicines to $46 From $42, Maintains Outperform Rating | MT |
May. 08 | Revolution Medicines Q1 Net Loss Narrows | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+37.76% | 6.54B | |
+58.71% | 55.07B | |
-2.04% | 41.79B | |
+44.36% | 40.22B | |
-8.29% | 28.17B | |
+11.89% | 26.28B | |
-21.01% | 18.93B | |
+6.45% | 13.03B | |
+28.17% | 12.26B | |
+25.42% | 12.21B |
- Stock Market
- Equities
- RVMD Stock
- News Revolution Medicines, Inc.
- Revolution Medicines Files Mixed-Securities Shelf